The technology landscape for detection of DNA methylation in cancer liquid biopsies
DNA methylation is a well-studied epigenetic factor and has become a powerful player in the cancer biomarker research field. Together with the rising interest in methylation biomarkers, the technological advances for the detection of DNA methylation have been immense. This has led to a plethora of d...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Epigenetics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15592294.2025.2453273 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832546486222585856 |
|---|---|
| author | Isabelle Neefs Joe Ibrahim Marc Peeters Guy Van Camp Ken Op de Beeck |
| author_facet | Isabelle Neefs Joe Ibrahim Marc Peeters Guy Van Camp Ken Op de Beeck |
| author_sort | Isabelle Neefs |
| collection | DOAJ |
| description | DNA methylation is a well-studied epigenetic factor and has become a powerful player in the cancer biomarker research field. Together with the rising interest in methylation biomarkers, the technological advances for the detection of DNA methylation have been immense. This has led to a plethora of different methods. The first methods were established for DNA methylation detection in genomic DNA, while new methods have focused more on compatibility with the emerging interest of cell-free DNA (cfDNA) from liquid biopsies. As DNA methylation detection in cfDNA brings its own challenges, a shift from the gold standard bisulfite conversion towards enzymatic conversion methods can be observed in recent years. In this review, we aim to summarize the classic and more recent DNA methylation detection methods for liquid biopsies. Importantly, the few existing European Certified In Vitro Diagnostics (CE-IVD) clinical applications for liquid biopsies are also described, underlining the potential of DNA methylation as a detection biomarker in cfDNA. Furthermore, we provide some insights into how the field might evolve in the future, where we believe enzymatic conversion might become a new gold standard and direct sequencing methods, such as ONT-sequencing, will get an important place in the epigenetic research field. Lastly, we believe that multi-omics technologies, which can combine diverse types of biomarkers, will most likely become more important in future clinical applications. Moreover, novel recent technologies are being developed and show promising clinical applications. Taken together, methylation biomarkers are becoming more important for clinical implementation. |
| format | Article |
| id | doaj-art-bea790b053e841fc834264dfb1cf9ed0 |
| institution | Kabale University |
| issn | 1559-2294 1559-2308 |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Epigenetics |
| spelling | doaj-art-bea790b053e841fc834264dfb1cf9ed02025-02-03T06:50:10ZengTaylor & Francis GroupEpigenetics1559-22941559-23082025-12-0120110.1080/15592294.2025.2453273The technology landscape for detection of DNA methylation in cancer liquid biopsiesIsabelle Neefs0Joe Ibrahim1Marc Peeters2Guy Van Camp3Ken Op de Beeck4Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem, BelgiumCenter of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem, BelgiumCenter for Oncological Research (CORE), University of Antwerp, Wilrijk, BelgiumCenter of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem, BelgiumCenter of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem, BelgiumDNA methylation is a well-studied epigenetic factor and has become a powerful player in the cancer biomarker research field. Together with the rising interest in methylation biomarkers, the technological advances for the detection of DNA methylation have been immense. This has led to a plethora of different methods. The first methods were established for DNA methylation detection in genomic DNA, while new methods have focused more on compatibility with the emerging interest of cell-free DNA (cfDNA) from liquid biopsies. As DNA methylation detection in cfDNA brings its own challenges, a shift from the gold standard bisulfite conversion towards enzymatic conversion methods can be observed in recent years. In this review, we aim to summarize the classic and more recent DNA methylation detection methods for liquid biopsies. Importantly, the few existing European Certified In Vitro Diagnostics (CE-IVD) clinical applications for liquid biopsies are also described, underlining the potential of DNA methylation as a detection biomarker in cfDNA. Furthermore, we provide some insights into how the field might evolve in the future, where we believe enzymatic conversion might become a new gold standard and direct sequencing methods, such as ONT-sequencing, will get an important place in the epigenetic research field. Lastly, we believe that multi-omics technologies, which can combine diverse types of biomarkers, will most likely become more important in future clinical applications. Moreover, novel recent technologies are being developed and show promising clinical applications. Taken together, methylation biomarkers are becoming more important for clinical implementation.https://www.tandfonline.com/doi/10.1080/15592294.2025.2453273DNA methylationdetectioncancer |
| spellingShingle | Isabelle Neefs Joe Ibrahim Marc Peeters Guy Van Camp Ken Op de Beeck The technology landscape for detection of DNA methylation in cancer liquid biopsies Epigenetics DNA methylation detection cancer |
| title | The technology landscape for detection of DNA methylation in cancer liquid biopsies |
| title_full | The technology landscape for detection of DNA methylation in cancer liquid biopsies |
| title_fullStr | The technology landscape for detection of DNA methylation in cancer liquid biopsies |
| title_full_unstemmed | The technology landscape for detection of DNA methylation in cancer liquid biopsies |
| title_short | The technology landscape for detection of DNA methylation in cancer liquid biopsies |
| title_sort | technology landscape for detection of dna methylation in cancer liquid biopsies |
| topic | DNA methylation detection cancer |
| url | https://www.tandfonline.com/doi/10.1080/15592294.2025.2453273 |
| work_keys_str_mv | AT isabelleneefs thetechnologylandscapefordetectionofdnamethylationincancerliquidbiopsies AT joeibrahim thetechnologylandscapefordetectionofdnamethylationincancerliquidbiopsies AT marcpeeters thetechnologylandscapefordetectionofdnamethylationincancerliquidbiopsies AT guyvancamp thetechnologylandscapefordetectionofdnamethylationincancerliquidbiopsies AT kenopdebeeck thetechnologylandscapefordetectionofdnamethylationincancerliquidbiopsies AT isabelleneefs technologylandscapefordetectionofdnamethylationincancerliquidbiopsies AT joeibrahim technologylandscapefordetectionofdnamethylationincancerliquidbiopsies AT marcpeeters technologylandscapefordetectionofdnamethylationincancerliquidbiopsies AT guyvancamp technologylandscapefordetectionofdnamethylationincancerliquidbiopsies AT kenopdebeeck technologylandscapefordetectionofdnamethylationincancerliquidbiopsies |